The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVDTK.L Regulatory News (VDTK)

  • There is currently no data for VDTK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

26 Apr 2018 07:00

RNS Number : 1373M
Verditek PLC
26 April 2018
 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR"). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

Verditek PLC

("Verditek" or the "Company")

Board Changes

 

Verditek plc, (AIM: VDTK), the clean technology company, is delighted to announce the appointment of The Rt Hon Lord Willetts as Non-Executive Chairman, with immediate effect.

Lord Willetts served as Minister for Universities and Science from 2010 to 2014 in the Coalition government. He was Member of Parliament for Havant between 1992 and 2015 and is now a member of the House of Lords.

 

Lord Willetts has a wealth of business experience, serving also on the Boards of Surrey Satellite Technology Limited and The Biotech Growth Trust. He is also a Board Member at the UK Research and Innovation (UKRI) and a Visiting Professor at King's College London. In addition, he is the Chairman of the Eight Great Technologies Fund which recently announced a funding intiative with a group of major Chinese technology investors.

Concurrently, José Luis del Valle, Non-Executive Director of Verditek plc has informed the Board that he is under consideration to be nominated as the Non-Executive Chairman of a Spanish banking institution subject to regulatory approval by the Bank of Spain (Banco de España). As such, due to regulatory and legal requirements, he will not be able to continue in his capacity as a Non-Executive Director of Verditek plc. However, José Luis has requested, and it has been agreed, that his resignation will be effective May 9th 2018 to ensure the new Chairman, Lord David Willetts has all the necessary support on joining Verditek.

Lord Willetts commented: "I am excited to join Verditek as Chairman and, as a strong supporter of clean technologies, I look forward to guiding this forward-thinking business in its mission to commercialise green technologies. I believe that Verditek's innovative range of clean energy products will help to meet the growing demand for a greener, cleaner planet."

Dr. Geoff Nesbitt, former Chairman and Interim CEO of Verditek plc, said: "Lord Willetts has an outstanding track record in supporting the development of science and technology. His passion in these fields, combined with his extensive business experience and knowledge of the technology sector, will be hugely beneficial to Verditek. I would also like to take this opportunity to thank José Luis for his contribution to the Company and wish him well in his endeavours."

 

The information required by Schedule 2 paragraph (g) of the AIM Rules for Companies in respect of Lord Willetts is set out in the Appendix.

 

Enquiries:

Verditek plc

Geoffrey Nesbitt (Interim CEO) enquiries@verditek.com

Whiteoaks Consultancy 

Mary Fitzgerald +44 (0) 7795 284440

Bekki Bushnell +44 (0) 7841 698586

verditek@whiteoaks.co.uk 

Stockdale Securities Limited (NOMAD and Broker)

Antonio Bossi/David Coaten +44 (0) 20 7601 6100

www.stockdalesecurities.com 

 

Appendix

Regulatory disclosures (in accordance with Rule 17 and Schedule Two, paragraph (g), of the AIM Rules for Companies):

Lord David Lindsay Willetts, aged 62, is, or has been during the last five years, a director of the following companies:

Current directorships:

Genome Research Limited

Marchmount Executive Services Limited

Sirius Constellation Limited

Surrey Satellite Technology Limited

The Biotech Growth Trust Plc

Eight Great Technologies Fund

The Francis Crick Institute Limited

Vantix Diagnostics, Inc.

 

Previous directorships:

Borough of Havant Sport and Leisure Trust

 

Lord Willetts is also a member of the board of the following organizations:

Biotech Industry Association

British Science Association

Science Museum

The Francis Crick Institute

The Resolution Foundation

UK Research and Innovation (UKRI)

 

No further disclosures are required under Rule 17 and Schedule Two, paragraph (g), of the AIM Rules for Companies.

 

 

About Verditek

Verditek plc (AIM: VDTK), the clean technology company, is headquartered in London. Verditek is dedicated to commercialising proven technology that can deliver significant competitive advantage compared to conventional industrial solutions. From light-weight solar modules, cutting edge de-odourisation, and ground-breaking CO2 capture, Verditek is realising tomorrow's technologies today.

 

For further information, please visit verditek.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEELFLVZFEBBF
Date   Source Headline
7th Sep 20223:19 pmRNSInterim Report for the Six Months to 30 June 2022
5th Aug 20225:10 pmRNSResult of AGM
8th Jul 20222:05 pmRNSSecond Price Monitoring Extn
8th Jul 20222:00 pmRNSPrice Monitoring Extension
8th Jul 20229:27 amRNSNotice of AGM
7th Jul 20221:04 pmRNSTR1: Notification of Major Holdings
7th Jul 202211:54 amRNSTR1: Notification of Major Holdings
30th Jun 20229:06 amRNSSecond Price Monitoring Extn
30th Jun 20229:00 amRNSPrice Monitoring Extension
30th Jun 20227:05 amRNSSubscription of Ordinary Shares to Raise £1.52m
30th Jun 20227:00 amRNSFinal Audited Results and Change of Address
27th Jun 202211:05 amRNSSecond Price Monitoring Extn
27th Jun 202211:00 amRNSPrice Monitoring Extension
27th Jun 20227:00 amRNSBradclad Group secures JV with Protan AB
21st Jun 20224:40 pmRNSSecond Price Monitoring Extn
21st Jun 20224:36 pmRNSPrice Monitoring Extension
3rd Feb 20227:00 amRNSSale of Investment in ICSI
26th Jan 20227:00 amRNSParagraf & Verditek - Project Update
29th Oct 20217:00 amRNSCrowd for Angels (UK) Limited Bond and Warrant
20th Sep 20217:00 amRNSGrant of Share Options
13th Sep 20217:00 amRNSInnovate UK Grant Award
26th Aug 20214:41 pmRNSSecond Price Monitoring Extn
26th Aug 20214:35 pmRNSPrice Monitoring Extension
26th Aug 20217:00 amRNSInterim Report for the six months to 30 June 2021
10th Aug 20217:00 amRNSCrowd for Angels (UK) Limited Bond
30th Jul 20217:00 amRNSResult of AGM
30th Jun 20217:00 amRNSFinal Audited Results
24th Jun 20217:00 amRNSFactory Update
1st Jun 20217:00 amRNSCrowd for Angels (UK) Limited Loan
7th Apr 20212:06 pmRNSSecond Price Monitoring Extn
7th Apr 20212:01 pmRNSPrice Monitoring Extension
6th Apr 20214:42 pmRNSSecond Price Monitoring Extn
6th Apr 20214:36 pmRNSPrice Monitoring Extension
1st Apr 20217:00 amRNSProduct Enhancement and Order Update
16th Mar 20214:41 pmRNSSecond Price Monitoring Extn
16th Mar 20214:36 pmRNSPrice Monitoring Extension
16th Mar 20212:06 pmRNSSecond Price Monitoring Extn
16th Mar 20212:01 pmRNSPrice Monitoring Extension
4th Feb 20214:41 pmRNSSecond Price Monitoring Extn
4th Feb 20214:36 pmRNSPrice Monitoring Extension
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:36 pmRNSPrice Monitoring Extension
28th Jan 20212:05 pmRNSSecond Price Monitoring Extn
28th Jan 20212:00 pmRNSPrice Monitoring Extension
28th Jan 202111:05 amRNSSecond Price Monitoring Extn
28th Jan 202111:00 amRNSPrice Monitoring Extension
27th Jan 202111:05 amRNSSecond Price Monitoring Extn
27th Jan 202111:00 amRNSPrice Monitoring Extension
27th Jan 20218:11 amRNSYear-end Update
29th Dec 20202:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.